Following stronger-than-expected fourth-quarter results, TD Cowen analyst Brian Morrison sees encouraging early signs from Canadian Tire Corporation’s (Canadian Tire Corporation Stock Quote, Chart, News, Analysts, Financials TSX:CTC.A) “True North” transformation strategy but remains cautious on near-term upside.
As reported by the Globe and Mail, the analyst maintained his “Hold” rating on the stock but raised his price target to $205.00 from $194.00 following results. The average Street target is $191.50.
In a Feb. 20 note, Morrison said Q4/25 results exceeded his expectations, driven by beats in both Retail and Financial Services. The company reported normalized EPS of $4.47, ahead of his $4.08 estimate and Street consensus of $3.87, though the shares fell 1.2% on the day.
Morrison highlighted “Retail gross margin strength and revenue growth at SportChek/Mark’s” as key positives.
“We are positive on True North drivers including loyalty/partnerships, new store formats, and DaiVID supporting growth at SportChek/Mark’s, and upward revision to its gross margin target (35%-plus),” he said.
However, he added that to become more constructive, he would need to see improved top-line performance at Canadian Tire Retail, which represents more than 70% of ex-petroleum revenue, as well as sustained SG&A operating leverage.
“The positive we take from the Q4/25 results was the Retail gross margin strength and outlook for it to be sustainable,” Morrison said. “To garner further multiple expansion, however, it is our view investors require True North to support heightened revenue growth at CTR … and the realization of sustainable SG&A leverage to support ‘higher quality’ EPS growth in a competitive Retail environment.”
While he sees “attractive value” at current levels over the mid-term as the company works to modernize its retail platform, Morrison believes improved visibility on sustainable 3-5% top-line growth at CTR and clearer operating leverage are needed before the stock can meaningfully outperform consensus or command a higher multiple.
-30-
Acumen Capital analyst Nick Corcoran has initiated coverage of NeuPath Health (NeuPath Health Stock Quote, Chart, News, Analysts, Financials TSXV:NPTH)… [Read More]
In an April 14 note, CIBC World Markets analyst Todd Coupland said he expects Celestica (Celestica Stock Quote, Chart, News,… [Read More]
Roth Capital Markets analyst Rohit Kulkarni maintained his “Buy” rating and $285.00 target on Amazon (Amazon Stock Quote, Chart, News,… [Read More]
National Bank Financial analyst Adam Shine upgraded Quebecor (Quebecor Stock Quote, Chart, News, Analysts, Financials TSX:QBR.B) to “Outperform” from “Sector… [Read More]
RBC Capital Markets analyst Drew McReynolds cut his target on Cogeco Communications (Cogeco Communications Stock Quote, Chart, News, Analysts, Financials… [Read More]
Roth Capital Markets analyst Rohit Kulkarni raised his target on CoreWeave (CoreWeave Stock Quote, Chart, News, Analysts, Financials NASDAQ:CRWV) to… [Read More]